QA: Cyteir Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001662244_2023_Cyteir_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001662244, Cyteir Therapeutics Inc

  xvar xval
0 AssetsCurrent 149,209,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,699,000
3 remainder_Assets 2,324,000
4 LiabilitiesCurrent 5,315,000
5 LiabilitiesNoncurrent 1,631,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,546,000
9 ResearchAndDevelopmentExpense 34,624,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,109,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 153,232,000
1 Liabilities 6,946,000
2 Expenses 48,170,000
3 Revenues 0
4 StockholdersEquity 146,286,000
5 NetIncome -46,061,000
6 ComprehensiveNetIncome -46,061,000
7 BaseVar 105,228,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.41
9 EconomicCapitalRatio 3.96

Edgar->Model Mapping

Feature Distribution

Change over Time